Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David S. who wrote (3099)	12/3/1997 8:52:00 PM
From: JOHN W.	Read Replies (2) of 6136

It is my understanding now (not confirmed) that evidence has been presented to SEC of a collaboration between 4 people that have/had a unproportional short position and one that had bought a very suspicious options position (Nov 20-21) when it was first discussed btwn Roche and Agouron to discontinue Thymitaq. Furthermore, the "conspiracy" theory against 1 analyst-2 managers and a few editorials will most likely be investigated. This could get very ugly. If anyone believes that there was something illegal re insider information, I would encourage you to contact the SEC. Think this is a paranoid thinking? Another poit: Vertex's PI is a collaboration with Glaxo. At least one influential person on the street has reffered to the Glaxo PI and the Vertex PI as 2 seperate PIs that will provide competition in 1998 for Agouron. This is a deliberate lie, and I am turning it over along with other information that I have obtained to the SEC.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next